ArticleAntimicrobial agents and chemotherapy2023
Trends in antifungal resistance in
Open access · greenAbstract readMulticenter Study
In one paragraph
Article in Antimicrobial agents and chemotherapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 31 citations in OpenAlex.
- Candidemia Epidemiology and Antifungal Resistance in Critically-ill Patients During and After COVID-19 Pandemic: Comparison Between Two Hospitals in Greece and Türkiye.Mycopathologia · 2026Article
- Species-specific antifungal resistance trends in yeast bloodstream isolates causing candidemia before, during, and after the COVID-19 pandemic: insights from the INVIFAR Mexican multicenter network.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Fpr1p mediates the synergistic effect of rapamycin or tacrolimus with caspofungin inJAC-antimicrobial resistance · 2026Article
- Trends in antifungal use characteristics in primary care in Spain, 2019 to 2024: a nationwide study.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2026Observational
- IFUCISTRATEGY: A Spanish Survey on the Management of Invasive Fungal Infection (IFI) in Critically Ill Patients.Journal of fungi (Basel, Switzerland) · 2026Article
- Candida species identified by MAL-DI-TOF and antifungal susceptibility in hospitalized patients with COVID-19 in Peru.Revista peruana de medicina experimental y salud publica · 2026Observational
- Candidemia in the intensive care unit before and during the COVID-19 pandemic: a cross-sectional analysis.IJID regions · 2026Article
- EmergentMicroorganisms · 2026Review
- Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2026Article
- Community-Onset Fungemias: Epidemiology and Genomic Characterization at a Tertiary-Care Hospital in Barcelona, Spain.Journal of fungi (Basel, Switzerland) · 2025Article
- Silent Persistence: Molecular Evidence of Clonal Transmission in Fluconazole-ResistantJournal of fungi (Basel, Switzerland) · 2025Article
- Machine Learning-Guided Design of High-Performance Antifungal Polymers againstACS polymers Au · 2025Article
- Epidemiology and outcomes of Candida-associated osteoarticular infections: A multicentre retrospective study from Turkey.Medical mycology · 2025Article
- Trends in Candidemia Over the Last 14 Years: A Comparative Analysis ofOpen forum infectious diseases · 2025Article
- Management of Intra-Abdominal Candidiasis in Intensive Care Setting: A Narrative Review.Journal of fungi (Basel, Switzerland) · 2025Review
- Resistance to Azoles inJournal of fungi (Basel, Switzerland) · 2025Article
- Antimicrobial and antiparasitic potential of lupeol: antifungal effect on theJournal of medical microbiology · 2025Article
- Analysis of pathogen distribution and serum procalcitonin level alterations in patients with type 2 diabetes mellitus complicated by urinary tract infections.Frontiers in endocrinology · 2025Article
- Phenotypic and genomic characterization of azole resistance in PortugueseFrontiers in fungal biology · 2025Article
- Increase in candidemia cases and emergence of fluconazole-resistantEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 13 institutions in 1 country.
Judith Díaz-GarcíaClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón , Madrid, Spain.ORCID 0000-0001-7216-8281
Marina MachadoClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón , Madrid, Spain.
Luis AlcaláClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón , Madrid, Spain.
Elena ReigadasClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón , Madrid, Spain.
Ana Pérez-AyalaHospital Universitario 12 de Octubre , Madrid, Spain.
Elia Gómez-García de la PedrosaHospital Universitario Ramón y Cajal , Madrid, Spain.
Fernando Gónzalez-RomoHospital Universitario Clínico San Carlos , Madrid, Spain.
María Soledad CuétaraHospital Universitario Severo Ochoa , Leganés, Spain.
Coral García-EstebanHospital Universitario de Getafe , Getafe, Spain.
Inmaculada Quiles-MeleroHospital Universitario La Paz , Madrid, Spain.
Nelly Daniela ZuritaHospital Universitario de La Princesa , Madrid, Spain.
María Muñoz-AlgarraHospital Universitario Puerta de Hierro , Majadahonda, Spain.
María Teresa Durán-ValleHospital Universitario de Móstoles , Móstoles, Spain.
Aida Sánchez-GarcíaLaboratorio Central de la CAM-URSalud-Hospital Infanta Sofía , San Sebastián de los Reyes, Spain.
Patricia MuñozClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón , Madrid, Spain.ORCID 0000-0001-5706-5583
Pilar Escribano *Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón , Madrid, Spain.ORCID 0000-0001-6254-4570
Jesus Guinea *Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón , Madrid, Spain.ORCID 0000-0002-7901-8355
CANDIMAD study group
Hospital General Universitario Gregorio Marañón · ESHospital Universitario de Getafe · ESHospital Universitario de Móstoles · ESHospital Universitario La Paz · ESInstituto de Salud Carlos III · ESHospital Clínico San Carlos · ESHospital Universitario Puerta de Hierro Majadahonda · ESUniversidad Complutense de Madrid · ESHospital Universitario de La Princesa · ESHospital Universitario Severo Ochoa · ESResearch Institute Hospital 12 de Octubre · ESHospital Universitario 12 De Octubre · ESHospital Universitario Infanta Sofía · ES
Funding
EC | European Regional Development Fund (ERDF)MEC | Instituto de Salud Carlos III (ISCIII) PI18/01155MEC | Instituto de Salud Carlos III (ISCIII) PI19/00074
Abstract
We previously conducted a multicenter surveillance study on
Indexed as
CandidaFluconazoleAmphotericin BAntifungal AgentsCandida albicansCandida parapsilosisDrug Resistance, FungalEchinocandinsGlycosidesHumansMicrobial Sensitivity TestsTractionTriterpenesAmphotericin BAntifungal AgentsEchinocandinsFluconazoleGlycosidesibrexafungerpTriterpenesantifungal resistanceCandidaC. parapsilosisMadridY132F
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.